To include your compound in the COVID-19 Resource Center, submit it here.

More from less

How Shire’s value could increase after spinning out its ADHD business

Shire plc (LSE:SHP; NASDAQ:SHPG) could increase in value while decreasing in size, but the market isn’t convinced.

Fourteen months after closing its acquisition of rare disease company Baxalta Inc., Shire is considering a flotation of its neuroscience business as part of an ongoing companywide strategic review.

On its 2Q17 earnings call,

Read the full 496 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE